Avidity Biosciences Inc (RNA)
29.51
+0.79
(+2.75%)
USD |
NASDAQ |
May 17, 16:00
29.30
-0.21
(-0.71%)
After-Hours: 20:00
Avidity Biosciences Shareholders Equity (Quarterly): 830.90M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 830.90M |
| December 31, 2023 | 500.76M |
| September 30, 2023 | 517.47M |
| June 30, 2023 | 559.18M |
| March 31, 2023 | 558.92M |
| December 31, 2022 | 578.08M |
| September 30, 2022 | 376.98M |
| June 30, 2022 | 374.35M |
| March 31, 2022 | 375.71M |
| Date | Value |
|---|---|
| December 31, 2021 | 381.43M |
| September 30, 2021 | 394.88M |
| June 30, 2021 | 264.48M |
| March 31, 2021 | 286.12M |
| December 31, 2020 | 306.22M |
| September 30, 2020 | 320.16M |
| June 30, 2020 | 330.30M |
| March 31, 2020 | 66.00M |
| December 31, 2019 | -65.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.36M
Minimum
Dec 2019
830.90M
Maximum
Mar 2024
386.48M
Average
376.34M
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 561.41M |
| Vertex Pharmaceuticals Inc | 18.55B |
| Codexis Inc | 79.27M |
| Sarepta Therapeutics Inc | 961.19M |
| PTC Therapeutics Inc | -893.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 951.47M |
| Total Liabilities (Quarterly) | 120.58M |
| Current Ratio | 12.47 |